InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,288.61
(
0.07%
)
Post# of 54032
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Johnny_C

Send PM Follow Ignore
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Johnny_C

Re: rawman post# 47642

Sunday, 02/17/2019 12:03:29 PM

Sunday, February 17, 2019 12:03:29 PM

Post# of 54032
It appears the investors don't seem hugely impressed with the FDA's J&J decision and its "touted" positive impact on VTGN.

Really, the J&J drug is estimated to in excess of 2 bil annual sales. But it will come with side effects and is not a long term solution

Again, why the significant drop in the VTGN share price?

Most in the know have a good idea why the price of VTGN has nothing to do with data or VTGN potential to be a blockbuster.

I am not going to tell you though. There is a clear pattern.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up